Attenuated Mycobacterium tuberculosis vaccines
OwnerWilliam R. Jacobs, Tsungda Hsu +2inventors
InventorsWilliam R. Jacobs, Tsungda Hsu, Stoyan Bardarov, Vasan Sambandamurthy
Life of this patent
Estimating the term…
Loading patent…
OwnerWilliam R. Jacobs, Tsungda Hsu +2inventors
InventorsWilliam R. Jacobs, Tsungda Hsu, Stoyan Bardarov, Vasan Sambandamurthy
Estimating the term…
Non-naturally occurring mycobacteria in the Mycobacterium tuberculosis complex are provided. These mycobacteria have a deletion of an RD1 region or a region controlling production of a vitamin, and exhibit attenuated virulence in a mammal when compared to the mycobacteria without the deletion. Also provided are non-naturally occurring mycobacteria that have a deletion of a region controlling production of lysine, and mycobacteria comprising two attenuating deletions. Vaccines comprising these mycobacteria are also provided, as are methods of protecting mammals from virulent mycobacteria using the vaccines. Also provided are methods of preparing these vaccines which include the step of deleting an RD1 region or a region controlling production of a vitamin from a mycobacterium in the M. tuberculosis complex.
A mycobacterium in the Mycobacterium tuberculosis complex, genetically engineered to be auxotrophic for a vitamin.
A non-naturally occurring Mycobacterium tuberculosis comprising a deletion of the entire RD1 region, wherein the M. tuberculosis with the RD1 deletion exhibits attenuated virulence in a mammal when compared to virulent M. tuberculosis without the deletion.
Dependencies are inferred from the claim text.